Avidity Biosciences vs Moderna
Avidity Biosciences vs Moderna, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Avidity Biosciences is on 53/100 and Moderna on 77/100.
Where each one leads
Avidity Biosciences
Leads on none of the measures we hold for both companies.
Moderna
- our overall score: 77/100 against 53/100
- agent readiness: 49/100 against 37/100
- domain rating: 79/100 against 46/100
- headcount: 6,297 against 445
- funding raised: $4.5B against $495M
- LinkedIn following: 780,086 against 37,705
At a glance
| Measure | Avidity Biosciences | Moderna |
|---|---|---|
| What it is | Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases. | Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics. |
| Category | Biotech, Drug Discovery, Genomics, Clinical Trials | Biotechnology, mRNA Technology, Vaccines, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2013 | 2010 |
| Headquarters | San Diego, United States | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Avidity Biosciences | Moderna |
|---|---|---|
| Employees | 445 | 6,297 |
| Open roles | Not published | 100 |
| Total funding | $495M | $4.5B |
| Latest round | IPO | Funding Round |
| LinkedIn followers | 37,705 | 780,086 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Avidity Biosciences | Moderna |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 77/100 |
| Traction | 60/100 | 60/100 |
| Team | Not published | 70/100 |
| Community | Not published | 13/100 |
| Search visibility | 22/100 | 46/100 |
| Quality | 68/100 | 90/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (37/100) | D (49/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 79/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Avidity Biosciences | Moderna |
|---|---|---|
| Hosting | Self Managed | AWS |
| CDN | Not detected | CloudFront |
| Frameworks | Jquery, Bootstrap | Next.js |
| Analytics | Google Tag Manager | Not detected |
What users say
| Measure | Avidity Biosciences | Moderna |
|---|---|---|
| Community ratingVisitor votes on StartupHub | Not published | 2.0/5 from 1 vote |
Avidity Biosciences vs Moderna: common questions
Which is better, Avidity Biosciences or Moderna?
On our 0-100 score Moderna rates higher (77/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Avidity Biosciences and Moderna compare on the numbers?
Moderna leads on our overall score (77/100 against 53/100), agent readiness (49/100 against 37/100), domain rating (79/100 against 46/100), headcount (6,297 against 445), funding raised ($4.5B against $495M), LinkedIn following (780,086 against 37,705).
Read the full Avidity Biosciences review and pricing or the Moderna review and pricing. You can also browse other Avidity Biosciences alternatives we track.